Regulon

Regulon: R-162

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.4591218Pr-3Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
79670 ENSG00000083223 ZCCHC6 Q5VYS8
857 ENSG00000105974 CAV1 A0A024R757
411 ENSG00000113273 ARSB P15848
800 ENSG00000122786 CALD1 Q05682
55654 ENSG00000135956 TMEM127 O75204
3142 ENSG00000136630 HLX Q14774
4864 ENSG00000141458 NPC1 O15118
8792 ENSG00000141655 TNFRSF11A Q9Y6Q6
5734 ENSG00000171522 PTGER4 P35408
5031 ENSG00000171631 P2RY6 Q15077
284119 ENSG00000177469 PTRF Q6NZI2
64764 ENSG00000182158 CREB3L2 Q70SY1
5770 ENSG00000196396 PTPN1 P18031

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DINOPROSTONEPTGER1Small moleculeAGONISTProstaglandin E2 receptor agonist40
CR-6086PTGER4Small moleculeANTAGONISTProstanoid EP4 receptor antagonist20
GRAPIPRANTPTGER4Small moleculeANTAGONISTProstanoid EP4 receptor antagonist20
RIVENPROSTPTGER4Small moleculeAGONISTProstanoid EP4 receptor agonist20
DIQUAFOSOLP2RY2Small moleculeAGONISTPyrimidinergic receptor P2Y6 agonist30
DIQUAFOSOL TETRASODIUMP2RY2Small moleculeAGONISTPyrimidinergic receptor P2Y6 agonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-162

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-08602FOXR2down-regulatesARID5AactivatesR-162156Drugs (6)
CMF-12804HOXA6down-regulatesARID5AactivatesR-162151Drugs (6)
CMF-13815ADAMTS8down-regulatesARID5AactivatesR-162156Drugs (6)
CMF-15286HCN1up-regulatesARID5AactivatesR-162152Drugs (6)
CMF-18012PRPF40Bdown-regulatesARID5AactivatesR-162158Drugs (6)
CMF-22652IDH1down-regulatesARID5AactivatesR-1621512Drugs (6)
CMF-26263CEP250down-regulatesARID5AactivatesR-162153Drugs (6)
CMF-30380RNF130down-regulatesARID5AactivatesR-162153Drugs (6)